Noticias y Actividades de Sinovac Biotech

Sinovac Biotech es una empresa que cotiza bajo el símbolo de cotización SVA (CN).

Ver el organigrama con sus 15 ejecutivos principales

Biografías más buscadas en Sinovac Biotech

• Weidong Yin, Executive Director and Chief Executive Officer
• Yu Wang, Director
• Chiang Li, Director

Recientes movimientos de ejecutivos en Sinovac Biotech

• Rui-Ping Xiao, Director, ha dejado la empresa  (noticia publicada el 5 de enero de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Sinovac Biotech.

Sinovac Biotech tiene 2.405 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y BioNTech (Alemania).

Popular M&A news in Biotecnología

• IMU Biosciences acaba de anunciar una recaudación de fondos de 53 millones de dólares. (publicado el 3 de junio de 2026).
• NewLimit acaba de anunciar una recaudación de fondos de 435 millones de dólares. (publicado el 3 de junio de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado el 1 de junio de 2026)..

Otros contactos sugeridos en el sector Biotecnología

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer en Inceptive
• Jan Van de Winkel - President and Chief Executive Officer en Genmab
• Valerie Hanote - Non-Executive Director en Eurofins

Saber más sobre el sector Biotecnología

Últimos comunicados de prensa de Sinovac Biotech

• SINOVAC and Bogotá Present BogotáBio, Colombia's First Public Vaccine Manufacturing Facility-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• Chilean President Boric Meets with SINOVAC Chairman and CEO Weidong Yin-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• Turkish Ambassador to China Visits SINOVAC in Beijing-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• SINOVAC Receives Visits from Bogotá Mayor and Colombian Ambassador to China in Beijing-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• SINOVAC Launches Its First Overseas Jointly Invested Vaccine Production Plant in Türkiye-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• SINOVAC's Vital Role in the Belt and Road Initiative: A Lifeline in the Fight Against Infectious Diseases-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• SINOVAC Chairman Meets with Chilean President to Foster Bilateral Cooperation-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• CPHI Barcelona 2023: SINOVAC Showcases Comprehensive Product Portfolio-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• SINOVAC Begins Phase I Trials of Bivalent Enterovirus Vaccine-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer-SINOVAC: Supply Vaccines to Eliminate Human Diseases
• View more press releases Close

Redes sociales sobre Sinovac Biotech

• Sinovac Biotech en Wikipedia, Google News y Yahoo Finance
• Sinovac Biotech en LinkedIn, Twitter y YouTube